Skip Navigation


Cardiovascular Research Advance Access first published online on January 8, 2009
This version [Corrected Proof] published online on January 26, 2009

Cardiovascular Research, doi:10.1093/cvr/cvp007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
82/2/361    most recent
cvp007v2
cvp007v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Podechard, N.
Right arrow Articles by Lecureur, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Podechard, N.
Right arrow Articles by Lecureur, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

NPC1 repression contributes to lipid accumulation in human macrophages exposed to environmental aryl hydrocarbons

Normand Podechard1, Eric Le Ferrec1, Amélie Rebillard1, Olivier Fardel1,2 and Valérie Lecureur1,*

1 Institut National de la Santé et de la Recherche Médicale (INSERM) U620, EA-SeRAIC, Team ‘Toxicity of polycyclic aromatic hydrocarbons’ (labellisée Ligue Nationale contre le Cancer), IFR140, Université de Rennes 1, Faculté des Sciences Pharmaceutiques et Biologiques, 2, Avenue du Pr L. Bernard, 35043 Rennes, France
2 Département HITC, Centre Hospitalier Universitaire, Rennes, France

* Corresponding author. Tel: +33 2 23 23 47 88; fax: +33 2 23 23 47 94. E-mail address: valerie.lecureur{at}univ-rennes1.fr

Aims: Aryl hydrocarbons (AHs), such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and benzo(a)pyrene (BP), are environmental contaminants promoting the development of atherosclerosis-related cardiovascular diseases. In order to identify molecular mechanisms involved in these effects, we have analysed AH-mediated regulation of the lipid trafficking Niemann–Pick type C1 protein (NPC1) and its contribution to AH-induced macrophage lipid accumulation.

Methods and results: Exposure of primary human macrophages to TCDD and BP decreased NPC1 mRNA expression in a time-dependent manner. NPC1 protein expression and NPC1-related acid sphingomyelinase activity were reduced in parallel. NPC1 was also similarly down-regulated in mice exposed to BP. Moreover, TCDD and BP were demonstrated to trigger lipid accumulation in human macrophages, as assessed by Oil Red O and Nile Red staining and cholesterol determination. Such lipid loading occurred at least partly in endosomal/lysosomal compartments as demonstrated by immunolabelling of lipid vesicles by the lysosome-associated membrane protein 1. These cellular phenotypic effects were found to be similar to those triggered by knock-down of NPC1 expression using siRNAs and were counteracted by NPC1 overexpression, thus supporting the contribution of NPC1 to AH-mediated lipid accumulation in macrophages. Finally, both NPC1 down-expression and lipid accumulation in response to TCDD were found to be abolished through knock-down of the AH receptor (AHR), a ligand-activated transcription factor mediating many effects of AHs.

Conclusion: Our data have shown that contaminants such as TCDD and BP repress NPC1 expression in macrophages in an AHR-dependent manner, which likely contributes to macrophage lipid accumulation caused by these environmental chemicals. Thus, NPC1 appears to be a new molecular target regulated by environmental AHs and putatively involved in their deleterious cardiovascular effects.

KEYWORDS Aryl hydrocarbon receptor; Lipid accumulation; Macrophage; Niemann–Pick type C1; TCDD


Time for primary review: 22 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.